DCM Stages Explained: Occult, Overt, and What They Mean for Your Dog

Why staging matters

When your dog is diagnosed with Dilated Cardiomyopathy, one of the first things you will hear is what "stage" the disease is in. This is not just academic labeling — the stage determines what treatment your dog needs, how aggressively to intervene, and what to expect going forward.

The staging system used by veterinary cardiologists comes from the American College of Veterinary Internal Medicine (ACVIM) consensus statements on the diagnosis and treatment of myxomatous mitral valve disease (MMVD) and, by extension, is applied to DCM as well. The ACVIM panel — a group of the world's leading veterinary cardiologists — developed this framework to create a common language for talking about heart disease progression.

Understanding where your dog falls on this spectrum gives you a clearer picture of what is happening inside their heart and what you can do about it.

The ACVIM staging system: an overview

The system uses four main stages — A, B, C, and D — with Stage B further divided into B1 and B2. Each stage represents a meaningful step in the progression of heart disease.

Here is the big picture before we dive into the details:

| Stage | What it means | Key point | |-------|--------------|-----------| | A | At risk, no disease yet | Screening recommended | | B1 | Disease present, no structural changes | Monitoring phase | | B2 | Disease present with structural changes | Treatment typically begins | | C | Current or past signs of heart failure | Active management required | | D | End-stage, resistant to standard therapy | Advanced and palliative care |

Now let us walk through each stage in detail.

Stage A: at risk but no disease detected

What Stage A means

Stage A includes dogs that are at increased risk for developing DCM but have no detectable disease at this time. There are no structural changes, no arrhythmias, no symptoms — and screening tests come back normal.

Who falls into Stage A?

• Doberman Pinschers — Given that 50-60% of Dobermans will develop DCM, every Doberman is considered Stage A until proven otherwise.
• Other predisposed breeds — Great Danes, Irish Wolfhounds, Boxers (for ARVC), Cocker Spaniels, Portuguese Water Dogs, and other breeds with documented genetic predisposition.
• Dogs with a family history — If a dog's parents or siblings were diagnosed with DCM, their risk is elevated.

What to do at Stage A

• Begin screening. For Dobermans, the recommendation is annual Holter monitoring and echocardiography starting at age 3 to 4 years.
• No medication is needed at this stage.
• Stay informed. Knowing that your dog is in a high-risk group allows you to plan financially and emotionally for ongoing monitoring.

Prognosis at Stage A

Many dogs in Stage A will never develop DCM. The purpose of the stage is to identify who needs watching, not to predict who will get sick. Regular screening is the strategy.

Stage B: disease is present but no symptoms yet

This is the stage often called occult DCM — the disease is present and detectable on screening tests, but your dog looks and feels completely normal. No coughing, no exercise intolerance, no difficulty breathing. From the outside, your dog seems perfectly healthy.

Stage B is where screening pays off. It is also where the terminology gets confusing, because veterinary cardiologists divide it into two substages that carry very different implications.

Stage B1: disease present, no cardiac enlargement

What Stage B1 means:

Your dog has evidence of DCM on screening tests, but the heart has not yet enlarged significantly. In practical terms, this often means:

• Arrhythmias detected on Holter — For Dobermans, this might mean more than 50 to 100 VPCs in 24 hours, or the presence of VT runs, without significant structural changes on echocardiogram.
• Mild echocardiographic changes — Perhaps slightly decreased function or borderline measurements that are not yet definitive for remodeling.

Treatment at Stage B1:

This is an area of ongoing discussion among cardiologists, and recommendations may vary. Some cardiologists will:

• Start anti-arrhythmic medication (like sotalol or mexiletine) if significant ventricular arrhythmias are present, to reduce the risk of sudden cardiac death.
• Begin pimobendan in some cases, though the strongest evidence for pimobendan in occult DCM is in dogs with structural changes (B2).
• Recommend supplements such as taurine, L-carnitine, omega-3 fatty acids, and CoQ10.
• Increase monitoring frequency — Holter and echo every 3 to 6 months instead of annually.

What this stage feels like for dog parents:

Stage B1 can be the most emotionally confusing stage. Your dog seems fine. They are running, eating, playing — and yet you have been told they have a serious heart condition. It can feel surreal. Trust the tests. The fact that your dog feels fine is actually the best possible scenario, because you have caught the disease early, before it has had a chance to cause damage that your dog can feel.

Stage B2: disease present with cardiac remodeling

What Stage B2 means:

Your dog still has no symptoms of heart failure, but the heart has now enlarged or its function has measurably declined. The echocardiogram shows:

• Increased left ventricular internal dimensions — the heart chamber is larger than it should be
• Decreased fractional shortening or ejection fraction — the heart is not squeezing as effectively
• Possible left atrial enlargement — the upper chamber may be dilating as the lower chamber struggles

This is still occult disease — your dog may still look perfectly normal — but the heart is working harder and starting to change shape.

Treatment at Stage B2:

This is where treatment has the strongest evidence base. The landmark PROTECT study (2012) demonstrated that:

Dobermans with occult DCM treated with pimobendan (Vetmedin) had a significantly longer time to onset of heart failure or sudden death — a median benefit of approximately 9 months compared to placebo (718 days vs. 441 days).

Standard treatment at Stage B2 typically includes:

• Pimobendan (Vetmedin) — now considered standard of care for occult DCM with structural changes, based on the PROTECT study.
• ACE inhibitors (benazepril or enalapril) — to reduce the workload on the heart and slow remodeling. These are often started at this stage, though the evidence for ACE inhibitors alone in occult DCM is less robust than for pimobendan.
• Anti-arrhythmic drugs — if significant arrhythmias are present.
• Supplements — taurine, L-carnitine, omega-3 fatty acids, CoQ10.
• Dietary considerations — ensuring adequate protein and appropriate caloric intake to prevent early muscle wasting.

Prognosis at Stage B2:

With treatment, many dogs remain in the occult stage for months to years before progressing to heart failure. Without treatment, progression tends to be faster. The PROTECT study showed that pimobendan extended the preclinical period significantly, and many cardiologists consider early treatment at this stage to be one of the most impactful interventions available.

However, it is important to understand that treatment slows progression — it does not stop or reverse it. DCM is currently a progressive disease, and most dogs will eventually progress to Stage C.

Stage C: congestive heart failure

What Stage C means

Stage C is when your dog develops clinical signs of congestive heart failure (CHF) — either for the first time or as a recurring event. This is what most people mean when they talk about a dog "going into heart failure."

What is happening in the body:

The weakened heart can no longer keep up with the body's demands. Blood backs up behind the failing ventricle, and fluid leaks into places it should not be:

• Left-sided heart failure produces pulmonary edema — fluid in the lungs. This is the most common presentation in dogs with DCM. Signs include coughing (especially at night or when lying down), increased respiratory rate, difficulty breathing, and restlessness.
• Right-sided heart failure produces fluid accumulation in the abdomen (ascites) and sometimes in the chest cavity (pleural effusion). Signs include a distended belly, decreased appetite, and lethargy.
• Biventricular failure involves both sides and can present with a combination of the above.

How Stage C typically presents

The transition from occult to overt DCM can happen gradually or suddenly. Some dogs have slowly worsening exercise intolerance over weeks, while others seem fine one day and are in respiratory distress the next. Common signs include:

• Increased resting respiratory rate — this is one of the earliest and most reliable indicators. A normal sleeping respiratory rate for a dog is under 30 breaths per minute. If your heart dog's sleeping rate consistently exceeds 30 to 40 breaths per minute, it may signal fluid buildup.
• Coughing — particularly at night, when lying down, or after exertion.
• Restlessness and inability to get comfortable — often because fluid in the lungs makes it hard to breathe when lying flat.
• Decreased appetite and energy.
• Fainting or collapse — sometimes related to arrhythmias or low cardiac output.

For all heart dog parents: Learn to count your dog's sleeping respiratory rate. This simple measurement, taken when your dog is resting calmly or sleeping, is one of the most valuable monitoring tools you have. Many cardiologists consider it even more informative than periodic clinic visits, because you can track it daily at home. Normal is typically under 30 breaths per minute. Your cardiologist may give you a specific threshold for your dog.

Treatment at Stage C

Stage C treatment is more intensive and typically involves:

Acute management (if the dog is in active heart failure):

• Furosemide (Lasix) — a powerful loop diuretic that removes excess fluid. This is the cornerstone of CHF treatment. In an acute crisis, furosemide may be given intravenously. For ongoing management, it is given orally, often two to three times daily.
• Oxygen therapy — if the dog is in respiratory distress.
• Additional vasodilators — to reduce the pressure the heart has to pump against.

Chronic management:

• Pimobendan — continued or started if not already on it.
• Furosemide — at the lowest effective dose to control fluid accumulation. The dose is often adjusted over time as the disease progresses, and many dogs need increasing doses.
• ACE inhibitors — typically continued or started.
• Spironolactone — a potassium-sparing diuretic that works synergistically with furosemide and has some anti-remodeling properties.
• Anti-arrhythmic drugs — continued or adjusted as needed.
• Dietary sodium restriction — becomes more important at this stage.
• Rest and activity modification — exercise should be limited to what the dog tolerates comfortably. No forced exercise, but gentle walks may still be appropriate.
• At-home respiratory rate monitoring — daily tracking of sleeping respiratory rate is essential.

Prognosis at Stage C

Prognosis at Stage C varies widely depending on the breed, severity, response to medication, and whether arrhythmias are well-controlled.

• For Dobermans: Historical studies showed median survival times of approximately 6 to 8 weeks after onset of CHF, but these figures predate modern treatments. With current multi-drug therapy (pimobendan, furosemide, ACE inhibitors, spironolactone, anti-arrhythmics), many Dobermans survive considerably longer, though the prognosis remains guarded. Some dogs do well for 6 to 12 months or more.
• For other breeds: Survival times vary. Some dogs with CHF live comfortably for a year or more with good medical management.

The first episode of CHF is not the end. Many dogs stabilize on medication and enjoy good quality of life for a meaningful period after their first heart failure episode. The key is aggressive, prompt treatment and attentive monitoring.

Stage D: refractory (end-stage) heart failure

What Stage D means

Stage D describes dogs whose heart failure symptoms persist despite maximum standard therapy. The term "refractory" means the disease is no longer responding adequately to conventional treatment.

Signs that a dog may have progressed to Stage D:

• Fluid accumulation recurs despite high doses of furosemide and other diuretics
• Respiratory rate remains elevated despite medication adjustments
• Persistent loss of appetite, weight loss, and muscle wasting (cardiac cachexia)
• Increasing weakness and lethargy
• Recurrent fainting episodes
• Kidney function may decline as a consequence of the failing heart and high diuretic doses

Treatment at Stage D

Treatment at this stage focuses on maintaining comfort and quality of life. Options may include:

• Higher doses of furosemide — though there are limits, as high doses can damage the kidneys.
• Adding additional diuretics — such as hydrochlorothiazide, to work alongside furosemide through a different mechanism (so-called "sequential nephron blockade").
• Torsemide — a more potent loop diuretic that some cardiologists switch to when furosemide is no longer sufficient.
• Sildenafil — may be used for dogs with pulmonary hypertension.
• Abdominocentesis — draining fluid from the abdomen if ascites is severe and causing discomfort.
• Thoracocentesis — draining fluid from the chest cavity if pleural effusion is compromising breathing.
• Nutritional support — high-calorie, palatable food to combat cachexia. This is not the time for strict dietary restrictions if they prevent the dog from eating.
• Anti-nausea medication — to help maintain appetite.
• Pain management and comfort care — as appropriate.

Prognosis at Stage D

Stage D is the most advanced stage, and prognosis is poor. Survival is typically measured in weeks to a few months, though individual variation exists. At this stage, the focus shifts from extending life to ensuring quality of life.

This is the stage where conversations about end-of-life care become important. Work closely with your veterinary team to establish clear quality-of-life markers and to have a plan in place. Many heart dog parents find it helpful to use a quality-of-life scale to objectively assess how their dog is doing day to day.

Occult vs. overt: understanding the terminology

You will hear the terms "occult" and "overt" DCM frequently. Here is what they mean:

• Occult DCM = Stages B1 and B2. The disease is detectable on testing but the dog has no outward symptoms. "Occult" simply means hidden. The dog looks healthy, but screening reveals the disease.
• Overt DCM = Stages C and D. The disease is producing visible symptoms — coughing, difficulty breathing, exercise intolerance, collapse. The disease is no longer hidden.

The transition from occult to overt can happen gradually or suddenly. In Dobermans, sudden death from a fatal arrhythmia can occur during the occult phase, which is one of the reasons screening and early treatment are so important.

A note on progression

It is natural to read through these stages and feel a sense of dread — a linear march from A to D. But there are a few things worth keeping in mind:

• Not every dog progresses through all stages. Some dogs in Stage A never develop DCM. Some dogs in Stage B1 remain stable for years.
• Treatment can significantly slow progression. The PROTECT study and other research have shown that early intervention extends the time before heart failure develops.
• Quality of life can be excellent in Stages B and early C. Many dogs with occult or even compensated overt DCM live happy, comfortable lives with appropriate treatment.
• Staging helps you and your vet make the best decisions at each point. It is a tool for action, not a sentence.

What you can do at every stage

Regardless of where your dog falls, these actions apply:

• Maintain regular veterinary and cardiology appointments. Screening saves lives at the early stages. Monitoring guides treatment at the later stages.
• Monitor sleeping respiratory rate at home. This is your daily window into your dog's cardiac status.
• Give medications exactly as prescribed. Cardiac drugs have narrow margins, and consistency matters.
• Communicate with your vet team. If something changes — energy level, appetite, breathing, behavior — report it promptly.
• Take care of yourself. Caring for a heart dog is emotionally taxing. You cannot pour from an empty cup. Lean on your community, your vet team, and the people who understand what this journey is like.

The bottom line

The ACVIM staging system gives you and your veterinary team a shared framework for understanding where your dog is in the course of heart disease and what to do about it.

• Stage A is about awareness and screening. No treatment needed, just vigilance.
• Stage B1 is early disease detection — the Holter or echo has found something, but the heart has not yet remodeled significantly. Monitoring intensifies; some treatment may begin.
• Stage B2 is where treatment has the strongest proven impact. Pimobendan, in particular, has been shown to delay the onset of heart failure by many months.
• Stage C is congestive heart failure. It requires active, multi-drug management, but many dogs stabilize and enjoy good quality of life.
• Stage D is end-stage disease where the focus shifts to comfort and quality of life.

Early detection through screening is the single most powerful tool available. If your dog is in a high-risk breed, start screening early and screen consistently. If your dog has been diagnosed, work closely with your veterinary cardiologist to optimize treatment at every stage. And remember — a diagnosis is not the end of the story. It is the beginning of a plan.